Stevenage, United Kingdom

Volker Germaschewski

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Volker Germaschewski: Pioneering Innovator in Antibody Therapeutics

Introduction: Volker Germaschewski, a prominent inventor based in Stevenage, GB, holds an impressive portfolio of 17 patents. His work primarily focuses on innovative therapies utilizing humanized anti-IL-18 antibodies and antigen binding proteins, which have significant implications for treating various diseases.

Latest Patents: Among his latest inventions, the method of treatment with humanized anti-IL-18 antibodies stands out. This patent discloses the creation of humanized antibodies, outlines their manufacture, and details methods for their application in treatment. Critical to this invention are screening methods, such as surface plasmon resonance, designed to identify antibodies with therapeutic potential. Additionally, Germaschewski's patent regarding antigen binding proteins covers those that bind to serum amyloid P component (SAP). It includes the encoding polynucleotides, pharmaceutical compositions, and manufacturing methods. Notably, these antigen binding proteins are designed for treating diseases linked to amyloid deposition, including systemic amyloidosis, local amyloidosis, Alzheimer’s disease, and type 2 diabetes.

Career Highlights: Volker Germaschewski has contributed significantly to the field of biomedicine during his career. He has worked with renowned companies such as Glaxo Group Limited and GlaxoSmithKline LLC, where he honed his skills in pharmaceutical innovation and research.

Collaborations: Throughout his career, Germaschewski has collaborated with notable colleagues in the industry, including Jonathan Henry Ellis and Susannah Karen Ford. Their combined expertise has fostered advancements in antibody therapies.

Conclusion: Volker Germaschewski is a distinguished inventor whose contributions to biomedicine have paved the way for innovative treatments. His latest patents not only showcase his dedication to advancing therapeutic options but also highlight his role within esteemed companies and collaborations in the field. The impact of his work continues to be felt as research on antibody therapies progresses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…